Status: Recruiting
The PREDICT Registry:
This is a prospective, non-interventional (observational) cohort study conducted within the medical network of the participating investigators and institutions. Patients meeting the eligibility criteria (see below) will be eligible for participation and the investigators will obtain written informed consent. A central Institutional Review Board (IRB), WCG IRB, will approve the protocol and each participating institution.
Participants needed: 3,000
Trial details
Age: 30-85Biological sex: FemaleType: ObservationalSponsor: PreludeDxUpdated: Apr 17, 2026Locations: 30
Eligibility criteria
Patient must have histologically confirmed ductal carcinoma in situ (DCIS) in a... [+6]
Patient tissue is insufficient to generate DCISionRT test results or required DC... [+6]